Cefalotin Production Cost Analysis 2020

Cephalothin (INN) is a first-generation cephalosporin antibiotic. It is an example of an intravenously administered agent having a spectrum like that of the antimicrobial spectrum to cefazolin and the oral agent cefalexin. Cephalothin is a type of semisynthetic, beta-lactam, first-generation cephalosporin antibiotic with bactericidal activity. Cephalothin binds and inactivates penicillin-binding proteins (PBP) that are situated on the inner membrane of the cell wall of teh bacteria. PBPs participate in the final stages of assembling the bacterial cell wall, along with reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains that are highly necessary for bacterial cell wall strength and rigidity. This leads to the weakening of the bacterial cell wall and causes cell lysis.

It is used usually during surgery and treating a broad spectrum of blood infections. It also finds application as an antimicrobial agent as well as an antibacterial drug.

Procurement Resource provides an in-depth cost analysis of Purified Cefalotin production. The report incorporates the manufacturing process with detailed process and material flow, capital investment, operating costs along with financial expenses and depreciation charges. The study is based on the latest prices and other economic data available. We also offer additional analysis of the report with detailed breakdown of all cost components (Capital Investment Details, Production Cost Details, Economics for another Plant Location, Dynamic Cost Model).

Reports

Cefalotin Production via Crystallisation
  • Cefalotin Production via Crystallisation

    This report presents a detailed cost analysis of cefalotin production from 2-TAC and 7-ACA using the crystallisation process.

    Analysis Basis: Germany

    Period of Analysis: Q3 2020

    Starting at USD 1799


Related Reports

Nicotinamide Production Process from (MPDA)

Rifampicin Production from Mixed Carbon Source
  • Rifampicin Production from Mixed Carbon Source

    This report presents the economics of rifampicin production from mixed carbon sources (peanut meal, soybean flour, glucose, and starch) via a typical fermentation process.

    Analysis Basis: Germany

    Period of Analysis: Q3 2020

    Starting at USD 1799


Lactoflavin Production from Fermentation Process

Methionine Production from Methional and Hydrogen Cyanide

Procurement Resource

Supply Demand and Market Analysis


Feasibility Studies


Techno-economic Evaluations


Investment Analysis


Multi-regional Cost Analyses

Evaluate Other Plant Locations

This report presents an analysis of capital and operating costs of a -based industrial plant. For those interested in economic assessments considering other plant locations, Procurement Resource offers optional analyses that complement this report.